Previous Article | Next Article ![]()
Journal of Virology, June 2007, p. 6757-6760, Vol. 81, No. 12
0022-538X/07/$08.00+0 doi:10.1128/JVI.00172-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

Department of Medicine, Division of Infectious Diseases, University of California—San Diego, SCRB, MC0711, 9500 Gilman Dr., La Jolla, California 92093,1 Liver Disease Research Center, Second Xiangya Hospital, Central South University, Changsha 410011, China2
Received 25 January 2007/ Accepted 30 March 2007
|
|
|---|
|
|
|---|
The Raf serine/threonine kinases are involved in the Ras-induced mitogen-activated protein kinase pathway (1, 15). They act downstream of Ras and are activated in a significant number of human malignancies (1, 15). There are three isoforms of Raf, A-Raf, B-Raf, and C-Raf, each displaying distinct expression profiles (1, 13, 15). C-Raf is ubiquitously expressed in many tissues, whereas A-Raf and B-Raf display tissue-specific expression (1, 15). Only A-Raf and C-Raf have been shown to translocate to mitochondria and regulate apoptosis (1). C-Raf, also known as Raf-1, exists in the cytoplasm as a multiprotein complex of 300 to 500 kDa consisting of heat shock protein 90 and dimeric protein 14-3-3. Binding of Ras to Raf displaces the 14-3-3 complex and unmasks amino acid residues critical for its activation. Mitochondrially localized Raf-1 protects cells from stress-mediated apoptosis. Raf-1 contains a central activation domain whose phosphorylation is activated by p21-activated protein kinase (PAK) at amino acids Ser338 and Ser339 or Src kinase at amino acid residues Y340 and Y341 (5, 8). B-Raf does not contain these tyrosine residues.
The results of this study demonstrate that HBx can stimulate the mitochondrial translocation of Raf-1 via oxidative stress. We previously showed that HBx itself targets to mitochondria and directly interacts with voltage-dependent anion channel 3 (VDAC3) (7, 10, 11, 12). HBx expression induces oxidative stress via calcium signaling and activates cellular kinases, which leads to the activation of transcription factors NF-
B and STAT-3 and others via phosphorylation (2, 3, 14). We observed that HBV-induced oxidative stress also stimulated the translocation of Raf-1 to mitochondria. This activation involves both the Src- and the PAK-mediated phosphorylation of the activation domain of Raf-1. Src inhibitors and dominant-negative PAK mutants abolished HBx-mediated Raf-1 mitochondrial translocation.
To demonstrate the role of HBx protein in regulating Raf-1 translocation, we first examined Raf-1 expression in Huh-7 cell lysates transfected with pCMVXF, which encodes the X gene placed under the transcriptional control of a cytomegalovirus (CMV) promoter containing a Flag sequence. The Western blot results show similar levels of Raf-1 expression in both untransfected and pCMVXF-transfected Huh-7 cellular lysates. (Fig. 1A). We next examined the association of Raf-1 with mitochondria. The results of Western blot analysis of mitochondria prepared according to a detailed procedure (9) from Huh-7 and pCMVXF cells (presented in Fig. 1B) demonstrate that both HBx protein and Raf-1 are associated with mitochondria. VDAC is used as a mitochondrial marker. To ensure that the Raf-1 and HBx signals were not due to cytoplasmic contamination, the lysates were also blotted for a cytoplasmic marker, lactate dehydrogenase (LDH). LDH expression was not observed in these mitochondrial preparations. The cytoplasmic fractions were also prepared and analyzed by a Western blot assay using anti-Raf, anti-Flag (which detects HBx), and anti-LDH (Fig. 1C). Raf-1 kinase levels were again similar to those described for Fig. 1A, indicating that not all Raf-1 kinase translocates to mitochondria, consistent with previous studies (1, 15). pCMVXF-transfected cellular lysates showed HBx expression, and LDH, used here as a cytoplasmic protein marker, was positive for both lysates. The vectors used thus far contained HBx under the transcriptional control of a CMV enhancer/promoter. To verify the role of HBx when expressed under the transcriptional control of the native promoter/enhancer in the context of the whole HBV genome, which recapitulates the viral life cycle, longer-than-genome-length HBV constructs were transfected into Huh-7 cells (6, 16). Analysis of these cells showed Raf-1 mitochondrial translocation, whereas the whole-genome construct, defective in HBx expression, failed to induce mitochondrial translocation of Raf-1, as did the untransfected cells (Fig. 1D). We further examined this phenomenon in transgenic mice harboring the HBx gene expressed under the control of its native promoter/enhancer (16). Mitochondria fractionated from liver tissues of HBx-transgenic mice were examined by a Western blot assay. As shown in Fig. 1D, Raf-1 also translocated to mitochondria in HBx-transgenic mice, as did HBx. This is the first report showing the association of the HBx with mitochondria in vivo using a transgenic-mouse model. We and others have previously shown that HBx targets to mitochondria using a variety of in vitro experimental strategies (7, 11, 12). In normal mouse liver tissue, Raf-1 association with mitochondria was not observed (Fig. 1E). These studies collectively provide evidence that HBx is associated with mitochondria and causes Raf-1 translocation to mitochondria both in cells transfected with HBx alone and in the context of the whole HBV genome. Moreover, a similar association was also seen in transgenic mice expressing HBx under the native promoter/enhancer (16).
![]() View larger version (18K): [in a new window] |
FIG. 1. HBx protein induces Raf-1 mitochondrial translocation. (A) Raf-1 levels in untransfected and pCMVXF-transfected Huh-7 cellular lysates. Western blot analysis was carried out using anti-Raf-1 kinase antibody. Anti-actin was used as a protein loading control. (B) Mitochondrial preparations from untransfected and pCMVXF-transfected Huh-7 cells were used for Western blot analysis using anti-Raf-1 kinase antibody. VDAC serves as a mitochondrial marker. Anti-Flag was used to monitor HBx expression, and anti-LDH was used to monitor for cytoplasmic contamination. (C) Cytoplasmic fractions from untransfected and pCMVXF-transfected Huh-7 cells were analyzed by Western blot assays using anti-Raf-1, anti-Flag (which detects HBx), and anti-LDH. LDH is used here as a cytoplasmic marker. (D) Mitochondria were fractionated (9) from untransfected Huh-7 cells and cells transfected with whole-HBV-genome plasmids (HBV1.3L) and an X-defective mutant plasmid of the HBV genome [HBV1.3L ( X)] (gift from J. Ou, USC). Western blot analysis was carried out using anti-Raf-1 kinase antibody and anti-electron transport factor (anti-ETF; a mitochondrial marker) antibody. HBx protein expression was monitored by first immunoprecipitating with anti-HBx antibody (16), followed by immunoblotting with the same antiserum (16). (E) Raf-1 mitochondrial translocation (9) in the HBx-transgenic mouse. Mitochondria were fractionated from normal and HBx-transgenic mice (gift from James Ou). HBx was expressed under its native promoter/enhancer (16). Western blot analysis was performed on the mitochondrial preparation. Lane 1, normal mouse liver tissue; lane 2, HBx-transgenic mouse liver Western blots using anti-Raf-1. ETF is used as a mitochondrial marker. HBx expression in the HBx-transgenic mice was determined using anti-HBx antibody by immunoprecipitation (IP), followed by immunoblot analysis with the same antibody (gift from Betty Slagle) (16).
|
![]() View larger version (32K): [in a new window] |
FIG. 2. HBx protein activates both Src-dependent tyrosine and PAK-1-dependent serine phosphorylation of Raf-1 and causes its mitochondrial translocation. (A) HBx activates serine phosphorylation of mitochondrial Raf-1. Western blot analysis was performed on isolated mitochondria fractionated from untransfected Huh-7 cells and those transiently transfected with the pCMV4X plasmid using the anti-Raf-1 Ser338 monoclonal antibody, which recognizes serine338-phosphorylated Raf-1 kinase (Upstate Biotechnologies). Anti-electron transport factor (anti-ETF) was used to detect ETF, a mitochondrial marker. HBx was monitored using anti-Flag antibody. (B) Pak-1 is required for Raf-1 translocation. Results are shown for Western blot analysis of isolated mitochondria prepared from untransfected Huh-7 cells (lane 1), Huh-7 cells transiently transfected with the pCMV4X plasmid (lane 2), Huh-7 cells cotransfected with pCMV4X-Flag (HBx), and dominant-negative Pak-1 protein (the PAK-1 inhibitory domain containing PAK83-149) (lane 2) using anti-Raf-1 antibody. ETF serves as a mitochondrial marker. HBx expression was monitored using anti-Flag antibody (an internal control). (C) Western blot analysis was carried out as described for panel B, except that a Src dominant-negative mutant (gift from R. Jove) was used for cotransfection along with the pCMV4X (HBx) plasmid (lane 2).
|
![]() View larger version (20K): [in a new window] |
FIG. 3. HBx induces Raf-1 mitochondrial translocation via oxidative stress. Western blot analysis of isolated mitochondria prepared from untransfected Huh-7 cells (lane 4) and Huh-7 cells transiently transfected with pCMV4X (lanes 1 to 3) is shown. Cells were either untreated (lanes 1 and 4) or treated with antioxidants pyrrolidine dithiocarbamate (PDTC; 50 µM) (lane 2) and N-acetyl cysteine (NAC; 30 mM) (lane 3) for 6 h each and subjected to Western blot assays using Raf-1 antibody. Electron transport factor (ETF) serves as a mitochondrial marker. Anti-Flag was used to detect HBx (internal control).
|
![]() View larger version (15K): [in a new window] |
FIG. 4. HBx protein directly binds mitochondrially associated Raf-1. (A) Mitochondrial preparations from untransfected and pCMV4X-transfected Huh-7 cells were first immunoprecipitated with anti-Raf-1, followed by immunoblotting with anti-Flag (which detects HBx) (lane 1) antibodies. (B and C) Western blot analysis of the mitochondrial preparations with anti-Flag (HBx) and anti-electron transport factor (anti-ETF) (a mitochondrial marker).
|
We thank James Ou for transgenic mice and HBV1.3L (
HBx) vectors and B. Slagle for anti-HBx sera.
Published ahead of print on 11 April 2007. ![]()
|
|
|---|
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»